Literature DB >> 1936901

Expression of arylhydrocarbon hydroxylase, epoxide hydrolases, glutathione S-transferase and UDP-glucuronosyltransferases in H5-6 hepatoma cells.

M Roques1, D Bagrel, J Magdalou, G Siest.   

Abstract

1. The presence of arylhydrocarbon hydroxylase (cytochrome P-450 IA1 dependent), glutathione S-transferase, two distinct forms of epoxide hydrolases and UDP-glucuronosyltransferases was detected in H5-6 hepatoma cell homogenates using model substrates, selective inhibitors and specific antibodies. 2. The activity of arylhydrocarbon hydroxylase decreased strongly at the first days after plating and remained at a minimal value (1.5 pmol/min per mg) after 5 days of culture. 3. The hydratation of trans-stilbene oxide catalyzed by the soluble form of epoxide hydrolase was very low (11.0 pmol/min per mg), whereas the hepatoma cells contained appreciable amounts of the membrane-bound epoxide hydrolase and glutathione S-transferase measured with cis-stilbene oxide as substrate (maximal specific activity: 1.46 and 2.73 nmol/min per mg, respectively). 4. These cells also glucuronidated 1-naphthol efficiently (6 nmol/min per mg) and, at a lower extent, bilirubin (12 pmol/min per mg). 5. Addition of fenofibrate (70 microM) into the culture medium for 1-3 days failed to significantly stimulate the activity of cytosolic epoxide hydrolase. Only bilirubin glucuronidation increased 2-fold after 2 days of presence of the drug.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936901     DOI: 10.1016/0306-3623(91)90077-j

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  8 in total

Review 1.  EET signaling in cancer.

Authors:  Dipak Panigrahy; Emily R Greene; Ambra Pozzi; Dao Wen Wang; Darryl C Zeldin
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activating NF-κB-p65.

Authors:  Junyang Li; Hongyi Liu; Biao Xing; Yanzhe Yu; Hui Wang; Gong Chen; Bing Gu; Guofeng Zhang; Dong Wei; Peiyuan Gu; Meng Li; Weixing Hu
Journal:  J Neurooncol       Date:  2012-03-02       Impact factor: 4.130

Review 3.  Regulation of inflammation in cancer by eicosanoids.

Authors:  Emily R Greene; Sui Huang; Charles N Serhan; Dipak Panigrahy
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-08-16       Impact factor: 3.072

4.  Distribution of soluble epoxide hydrolase, cytochrome P450 2C8, 2C9 and 2J2 in human malignant neoplasms.

Authors:  Ahmed E Enayetallah; Richard A French; David F Grant
Journal:  J Mol Histol       Date:  2006-09-07       Impact factor: 2.611

5.  Soluble epoxide hydrolase deficiency inhibits dextran sulfate sodium-induced colitis and carcinogenesis in mice.

Authors:  Wanying Zhang; Haonan Li; Hua Dong; Jie Liao; Bruce D Hammock; Guang-Yu Yang
Journal:  Anticancer Res       Date:  2013-12       Impact factor: 2.480

Review 6.  Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.

Authors:  Dipak Panigrahy; Arja Kaipainen; Emily R Greene; Sui Huang
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

7.  Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.

Authors:  Xiaolong Wei; Donghong Zhang; Xiaowei Dou; Na Niu; Wenhe Huang; Jingwen Bai; Guojun Zhang
Journal:  BMC Cancer       Date:  2014-11-18       Impact factor: 4.430

8.  Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis.

Authors:  Ali Mahmoudi; Alexandra E Butler; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Biomed Res Int       Date:  2021-12-26       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.